Inconsistent alignment with WHO TRS during prequalification preparation – evidence pack for WHO audits


Published on 28/01/2026

Addressing Inconsistent Alignment with WHO TRS During Prequalification Preparation

In the pharmaceutical industry, aligning with the WHO TRS (Technical Report Series) is crucial for securing prequalification (PQ) status. Yet, inconsistencies during preparation can lead to significant setbacks, compliance issues, and potential failures during regulatory inspections. This article guides pharmaceutical professionals through a structured playbook to address these challenges effectively.

For a broader overview and preventive tips, explore our WHO GMP Compliance.

By following the outlined actionable steps, personnel in Manufacturing, Quality Control (QC), Quality Assurance (QA), Engineering, and Regulatory Affairs (RA) can proactively mitigate risks, enhance alignment with WHO TRS, and ensure audit readiness.

Symptoms/Signals on the Floor or in the Lab

Identifying the symptoms of misalignment can prevent severe compliance failures. Common signals that indicate inconsistent alignment with WHO TRS during prequalification include:

  • Frequent deviations: Multiple deviations from standard operating procedures (SOPs) during production or testing.
  • Sampling errors: Inaccurate or
non-compliant sample collection and testing processes.
  • Documentation inconsistencies: Discrepancies in batch records or analytical results.
  • Non-compliance feedback: Issues raised during internal audits or mock inspections highlight non-compliance with WHO guidance.
  • Staff training gaps: Repeated instances of untrained staff conducting critical operations.
  • Likely Causes

    Understanding the root causes of inconsistent alignment with WHO TRS can help mitigate risks. Below are categorized likely causes:

    Category Examples
    Materials Substandard raw materials that do not meet WHO specifications.
    Method Outdated or inadequately validated methods that do not align with WHO recommendations.
    Machine Equipment failures or deviations in calibration affecting production quality.
    Man Insufficiently trained personnel leading to operational errors.
    Measurement Poor measurement practices yielding inaccurate data.
    Environment Non-compliance with environmental controls crucial for product safety.

    Immediate Containment Actions (First 60 Minutes)

    Rapid response is essential when symptoms are detected. Consider the following immediate actions:

    1. Containment: Halt affected processes immediately to prevent further deviation.
    2. Evaluate: Assess the scale of the deviation and identify potentially impacted lots.
    3. Notification: Inform relevant department heads (QA, RA, and operations) regarding the issue.
    4. Documentation: Record initial findings and actions taken in real-time to ensure traceability.
    5. Review: Examine SOPs and compliance checklists to determine which areas are non-compliant.

    Investigation Workflow

    Establishing a structured investigation workflow is critical. Collect the following data:

    • Batch records: Compare affected batches against compliant historical data.
    • Environmental monitoring data: Review air and surface samples from the production environment.
    • Employee reports: Gather insights from the personnel involved in production and quality checks.
    • Training records: Ensure all personnel involved were adequately trained.

    Interpreting the data will reveal correlations between identified symptoms and processes. Utilize trend analysis and graphical data representations for clarity.

    Root Cause Tools

    Employing root cause analysis (RCA) tools is paramount in identifying underlying issues. Here are three primary methods:

    • 5-Why Analysis: Best used for straightforward problems where you can drill down through sequential questioning.
    • Fishbone Diagram: Ideal for complex issues where multiple potential causes need mapping.
    • Fault Tree Analysis: Utilize when a systematic approach is required to pinpoint failure points.

    When choosing a tool, consider your team’s familiarity with the approaches and the complexity of the issue at hand.

    CAPA Strategy

    The Corrective and Preventive Action (CAPA) strategy is critical in response to identified discrepancies:

    • Correction: Immediate correction of the problems identified (e.g., re-training for involved personnel).
    • Corrective Actions: Implement process modifications based on root cause findings to prevent recurrence.
    • Preventive Actions: Enhance compliance through regular training and updated SOPs reflective of WHO TRS regulations.

    Control Strategy & Monitoring

    Establishing a robust control strategy is essential for ongoing compliance:

    • Statistical Process Control (SPC): Regularly analyze process data for trends that indicate deviation before reaching a critical failure point.
    • Sampling plans: Develop and follow detailed sampling plans that align with WHO specifications.
    • Alarm systems: Implement alarms for deviations in critical production parameters to alert personnel immediately.
    • Verification: Conduct periodic verifications to confirm the effectiveness of mitigation strategies.

    Validation / Re-qualification / Change Control Impact

    Assessing the impact of any changes is critical to maintaining compliance:

    • Validation: Revalidate processes affected by the identified inconsistency to ensure adherence to WHO standards.
    • Re-qualification: Determine if equipment or processes require re-qualification due to modifications.
    • Change Control: Utilize a structured change control process to document any modifications made as a result of the CAPA steps.

    Inspection Readiness: What Evidence to Show

    To be adequately prepared for inspections, ensure the following documentation is readily available:

    Related Reads

    • Records: Comprehensive records of all deviations, investigations, and CAPA efforts.
    • Logs: Training logs for all affected personnel ensuring compliance with qualification requirements.
    • Batch documentation: Detailed batch production records and testing log data.
    • Deviation reports: Clearly documented deviations that detail initial findings and corrective actions taken.

    Maintain these records in an accessible and organized manner to facilitate inspection processes.

    FAQs

    What should be included in the evidence pack for WHO audits?

    A comprehensive evidence pack should include batch records, deviation reports, CAPA documentation, training logs, and environmental monitoring data.

    How often should I review compliance with WHO TRS?

    Compliance should be reviewed regularly, ideally with every batch production process and during periodic internal audits.

    What is the best way to train staff on SOPs related to WHO TRS compliance?

    Utilize a combination of classroom training, practical demonstrations, and assessments to ensure effective understanding and adherence.

    What steps should I take when a deviation occurs?

    Immediately contain the issue, notify relevant departments, document all actions, and initiate an investigation to ascertain root causes.

    How do I conduct a 5-Why analysis effectively?

    Engage stakeholders in brainstorming sessions to explore each “why,” diving deeper until the root cause is identified.

    What key performance indicators (KPIs) should be monitored for WHO compliance?

    Monitor metrics such as the number of deviations, training compliance rates, and SPC data trends to ensure alignment with WHO TRS.

    When is re-validation necessary after a CAPA?

    Re-validation is necessary when changes significantly affect production processes, equipment, or controls that could impact product quality.

    How can I ensure ongoing inspection readiness?

    Implement a continuous monitoring and review process, alongside regular training and audits to maintain compliance and readiness for inspections.

    How often should environmental monitoring be conducted?

    Frequency is contingent upon the production environment and regulatory requirements but should be conducted routinely as per QMS standards.

    What role do external auditors play during WHO PQ preparation?

    External auditors can provide an objective assessment of compliance gaps and suggest areas for improvement, boosting preparedness.

    Where can I find the latest WHO TRS guidelines?

    Current WHO TRS guidelines can be accessed via the WHO Technical Report Series official page.

    What are the main differences between WHO PQ and FDA inspection?

    WHO PQ focuses primarily on product quality for international distribution, while FDA inspections emphasize compliance with U.S. pharmaceutical regulations and standards.

    Pharma Tip:  WHO GMP gap identified during remediation planning – avoiding repeat WHO observations